| Structure |
Chemical Name |
CAS |
MF |
 |
loteprednol Impurity 7 |
82034-20-6 |
C24H33ClO7 |
 |
Sitagliptin Impurity 28 |
898543-70-9 |
C32H25F12N9O2 |
 |
Vilanterol Impurity 3 Triphenylacetate |
503070-62-0 |
C23H31Cl2NO5 |
 |
Empagliflozin Impurity 33 |
|
|
 |
Sugammadex Impurity 21 |
2412952-93-1 |
C72H113NaO48S8 |
 |
4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzaldehyde trihydrochloride |
1254176-45-8 |
C18H30N4O |
 |
ネブラミン |
34051-04-2 |
C12H26N4O5 |
 |
Remifentanil Impurity 1 (RTF-02) |
938184-94-2 |
C16H21N3O2 |
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
 |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
|
|
Zopiclone Impurity 13 |
|
|
 |
1-メチルインドリン-2,3-ジオン |
2058-74-4 |
C9H7NO2 |
 |
1-bromo-3-(4-ethoxybenzyl)benzene |
898538-17-5 |
C15H15BrO |
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
1318794-28-3 |
C22H27ClO7 |
 |
Brivaracetam Impurity |
2432911-37-8 |
C11H22O3 |
|
|
Cefminox Sodium impurity 5 |
|
|
 |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
 |
Nimodipine Impurity 12 |
39562-18-0 |
C19H22N2O6 |
 |
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
878757-08-5 |
C19H21NOS |
|
|
Capecitabine Impurity 10 |
|
|
|
|
Carfilzomib Impurity C |
|
|
 |
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
|
|
Cefodizime Impurity 2 |
|
|
 |
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
|
|
DecitaBine Impurity 11 |
|
|
|
|
Isavuconazole Impurity 21 |
|
|
|
|
Isavuconazole Impurity 27 |
|
|
|
|
Istradefylline Impurity E |
|
|
|
|
Linagliptin Impurity 41 |
|
|
|
|
PalBociclib Impurity 17 |
|
|
|
|
PalBociclib Impurity 24 |
|
|
|
|
Posaconazole Impurity 12 |
|
|
 |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
 |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
 |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
|
|
Tenofovir impurity Q |
|
|
 |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
 |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
 |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
 |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
 |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
 |
7'-メチル-2'-プロピル-2,5'-BI-1H-ベンズイミダゾール |
884330-09-0 |
C18H18N4 |
![5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol](/CAS/GIF/112935-93-0.gif) |
5-Des[2-(tert-butylaMino)] BaMbuterol-5-ethanol |
112935-93-0 |
C14H20N2O5 |
 |
Deoxy Fesoterodine |
895137-81-2 |
C26H37NO2 |
![Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/GIF/72901-16-7.gif) |
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
72901-16-7 |
C20H17NO3 |
![(6R,7R)-7-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide](/CAS/GIF/934986-48-8.gif) |
(6R,7R)-7-((Z)-2-(2-aMinothiazol-4-yl)-2-(hydroxyiMino)acetaMido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 5-oxide |
934986-48-8 |
C14H13N5O6S2 |
![(2S)-1-[(2S)-2-Methyl-3-Methylsulfinylpropanoyl]pyrrolidine-2-carboxylic acid](/CAS/20130318/GIF/CB32605020.gif) |
(2S)-1-[(2S)-2-Methyl-3-Methylsulfinylpropanoyl]pyrrolidine-2-carboxylic acid |
78636-31-4 |
C14H22N2O6S2 |
|
|
Mixture of diastereoisoMers of (6S)-6-N-[3-[(6S)-2-aMino-4,5, 6,7-tetrahydro-1,3-benzothiazol-6-yl]-1-ethyl-2-Methylpropyl]- 4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diaMine |
|
|
|
|
penilloic acids of piperacillin |
|
|
 |
2-PyrazinecarboxaMide, 6-nitro-3,4-dihydro-3-oxo- |
259793-97-0 |
C5H4N4O4 |
|
|
Rosuvastatin Impurity 53 |
|
|
 |
Sulbactam Impurity 8 |
75527-88-7 |
C8H10BrNO5S |
 |
Tenofovir Impurity 64 |
1878175-76-8 |
C13H23N5O8P2 |
|
|
Ticagrelor Impurity 65 |
|
|
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
|
|
Ampicillin Impurity A |
|
|
|
|
Oxacillin Sodium Impurity B(EP) |
|
|
 |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
 |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
 |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
|
|
Moxifloxacin EP Impurity E HCl |
|
|
 |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
 |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
 |
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
 |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
 |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
 |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
 |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
 |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
 |
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
 |
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
 |
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
 |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
 |
4-クロロ-3-ヒドロキシブチロニトリル |
105-33-9 |
C4H6ClNO |
 |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
 |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
 |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
 |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
 |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
![(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180629/GIF/1598416-05-7.gif) |
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
 |
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
 |
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
|
|
Empagliflozin Impurity 34 |
|
|
 |
Sugammadex Impurity 22 |
2412952-94-2 |
C72H113NaO48S8 |
 |
Febuxostat |
1312815-36-3 |
C20H25NO4S |
 |
Itraconazole Impurity 34 |
103661-14-9 |
C14H15Cl2N3O5S |
 |
Lansoprazole Impurity 34 |
1357726-93-2 |
C7H8N2O3 |
 |
Meloxicam Impurity 1 HCl |
929568-25-2 |
C4H7ClN2O |
 |
Palonosetron Impurity 11 |
2216753-67-0 |
C18H24N2O |
|
|
Vonoprazan Impurity 4 |
|
|
|
|
Cinacalcet impurity K |
|
|
 |
Valsartan Impurity 13 |
|
C24H29N5O3 |
 |
Valsartan Impurity 27 |
|
C24H29N5O3 |
|
|
Etoricoxib Impurity 6 |
|
|
|
|
Ezetimibe impurity 3 |
|
|
 |
bis(1-benzylpiperidin-3-yl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
166808-97-5 |
C16H16N2O6 |
 |
Ticagrelor Imp.J |
2248538-63-6 |
C14H20ClN5O4S |